Consensus CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
15.94 USD +0.69% Intraday chart for CareDx, Inc +2.84% +32.83%

Evolution of the average Target Price on CareDx, Inc

Price target over the last 5 years

History of analyst recommendation changes

df7b58c3857217e120.EYDHuPAo4PG-tBBc8Xvp2hBdVeq_23-OyiKd7ZhMckQ.YMz_0sRNiKLIhlUuxBODvyEoGrL8iiv0oRH8tMsHRBV5trTIunqDu8eAYw~128df1a1637df4a9155d76054c81c692
Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating MT
Raymond James Downgrades CareDx to Market Perform From Outperform MT
Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating MT
North American Morning Briefing : Stock Futures -3- DJ
Stephens Upgrades CareDx to Overweight From Equalweight, Price Target is $10 MT
Raymond James Upgrades CareDx to Outperform From Market Perform, Price Target is $12 MT
BTIG Research Downgrades CareDx to Neutral From Buy MT
Goldman Sachs Lowers Price Target on CareDx to $13 From $25, Maintains Buy Rating MT
Stephens Downgrades CareDx to Equalweight From Overweight, Adjusts Price Target to $9 From $19 MT
Craig-Hallum Downgrades CareDx to Hold From Buy, Adjusts Price Target to $9 From $26 MT
Raymond James Downgrades CareDx to Market Perform From Strong Buy, $24 Price Target MT
Craig-Hallum Adjusts CareDx's Price Target to $26 From $32, Keeps Buy Rating MT
BTIG Adjusts Price Target on CareDx to $25 From $28, Maintains Buy Rating MT
Goldman Sachs Adjusts CareDx's Price Target to $25 From $29, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on CareDx to $29 From $40, Maintains Buy Rating MT
Raymond James Adjusts CareDx's Price Target to $24 From $26, Maintains Strong Buy Rating MT
BTIG Adjusts Price Target on CareDx to $28 From $37, Maintains Buy Rating MT
Raymond James Adjusts Price Target on CareDx to $35 From $45, Reiterates Strong Buy Rating MT
Goldman Sachs Adjusts Price Target for CareDx to $45 From $50, Maintains Buy Rating MT
Stephens Initiates CareDx at Overweight with $50 Price Target MT
Raymond James Adjusts CareDx's Price Target to $52 from $90, Maintains Strong Buy Rating MT
Raymond James Adjusts CareDx PT to $90 From $108, Maintains Strong Buy Rating MT
CAREDX : Piper Sandler Adjusts Price Target on CareDx to $110 From $100, Reiterates Overweight Rating MT
CAREDX : BTIG Analyst Assumes Coverage on CareDx at Buy, Sets $115 Price Target MT
CAREDX : Raymond James Adjusts Price Target on CareDx to $108 From $90, Maintains Strong Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
15.94 USD
Average target price
14.75 USD
Spread / Average Target
-7.47%
High Price Target
18 USD
Spread / Highest target
+12.92%
Low Price Target
12 USD
Spread / Lowest Target
-24.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CareDx, Inc

Craig-Hallum
Raymond James
Stephens Inc.
BTIG
Goldman Sachs
Piper Sandler
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings